共 315 条
[4]
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study
[J].
GYNECOLOGIC ONCOLOGY,
2014, 133 (03)
:433-438